The World Health Organization predicts that 30.2 million people worldwide will be diagnosed with cancer in 2040. In response to this challenge, the cancer-care landscape is rapidly evolving. Ground-breaking innovations that have recently emerged across the cancer-care ecosystem include blood-based tests that can detect multiple cancers simultaneously, at-home screenings and treatment, customized vaccines to deliver targeted treatments, and imaging technologies less harmful than their predecessors. Panelists will hypothesize what it may be like to have cancer in 2040 and will discuss how we might reinvent the future of cancer care, devising novel approaches to prevention, screening, and treatment. 

Moderator

Margarete Anderson

Managing Director, Deloitte, Board Member, FasterCures

Speakers

Jeff Allen

President and CEO, Friends of Cancer Research

Danielle Carnival

Deputy Assistant to the President for the Cancer Moonshot; Deputy Director for Health Outcomes, Office of Science and Technology Policy, The White House

Gianrico Farrugia

CEO, Mayo Clinic

David Fredrickson

Executive Vice-President, Oncology Business Unit, AstraZeneca

Gary Puckrein

President, National Minority Quality Forum